Edition:
United States

Galena Biopharma Inc (GALE.OQ)

GALE.OQ on NASDAQ Stock Exchange Capital Market

0.31USD
15 Dec 2017
Change (% chg)

$-0.00 (-1.56%)
Prev Close
$0.32
Open
$0.33
Day's High
$0.33
Day's Low
$0.28
Volume
196,424
Avg. Vol
94,985
52-wk High
$3.60
52-wk Low
$0.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.158
Jun '17 0.00 -0.190
Mar '17 0.00 -0.086
FY 2016 Dec '16 0.00 -0.171
Sep '16 0.00 -0.415
Jun '16 0.00 0.893
Mar '16 0.00 -1.461
FY 2015 Dec '15 0.00 -1.334
Sep '15 0.00 -0.785
Jun '15 3.38 -1.941
Mar '15 0.00 -1.221
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 1 -0.15 -0.15 -0.15 -0.66
Quarter Ending Mar-18 1 -0.14 -0.14 -0.14 -0.61
Year Ending Dec-17 1 -0.59 -0.59 -0.59 -2.52
Year Ending Dec-18 1 -0.84 -0.84 -0.84 -1.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. -- 40.75 45.35
P/E Low - Last 5 Yrs. -- 23.60 24.23
Beta 1.96 0.92 0.91
Price to Sales (TTM) -- 3.92 5.95
Price to Book (MRQ) 0.90 4.85 5.68
Price to Tangible Book (MRQ) -- 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 23.13 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 5.15 5.62
Sales - 5 Yr. Growth Rate -- 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 61.97 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago 73.87 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate -35.32 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 0.95 3.50 3.56
LT Debt to Equity (MRQ) 0.00 11.01 13.38
Total Debt to Equity (MRQ) 83.15 17.15 19.38
Interest Coverage (TTM) -- 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,784.27 18.50 15.63
Operating Margin (TTM) -- 14.76 6.56
Operating Margin - 5 Yr. Avg. -1,832.94 14.33 11.00
Pre-Tax Margin (TTM) -- 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -2,046.43 14.64 11.41
Net Profit Margin (TTM) -- 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -2,052.96 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 945,342,213 851,801,741
Net Income/Employee (TTM) -1,250,857 110,573,246 99,542,701
Receivable Turnover (TTM) -- 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.56
Asset Turnover (TTM) 0.00 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.60 11.86 11.31
Return on Assets - 5 Yr. Avg. -54.05 12.86 12.28
Return on Investment (TTM) -67.51 15.06 14.43
Return on Investment - 5 Yr. Avg. -112.22 16.81 16.07
Return on Equity (TTM) -90.82 16.55 16.01
Return on Equity - 5 Yr. Avg. -184.67 17.82 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 77.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galena Biopharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.13%
# of Holders: 50
Total Shares Held: 10,574,937
3 Mo. Net Change: -278,893
# New Positions: 4
# Closed Positions: 16
# Increased Positions: 13
# Reduced Positions: 27
# Net Buyers: -14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.